Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:ONNVF)

0.4309 -0.0080 (-1.82%)
Streaming Delayed Price Updated: 9:30 AM EDT, Aug 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 413
Open 0.4389
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.4389
Today's Range 0.4309 - 0.4309
52wk Range 0.3870 - 1.320
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Combines Targeted Cancer Therapy, Nanotechnology and AI
Via Investor Brand Network
Topics Artificial Intelligence
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Closes CAD$5 Million Private Placement to Advance Oncology Programs
Via Investor Brand Network

Performance

YTD
+0.5%
+0.5%
1 Month
-2.3%
-2.3%
3 Month
-43.1%
-43.1%
6 Month
+0.5%
+0.5%
1 Year
-67.4%
-67.4%

More News

Read More
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Moves Lead Oncology Candidate Toward Future Clinical Studies
Via Investor Brand Network
Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF): Combining Three Emerging Frontiers in Cancer Drug Development
Via Investor Brand Network
Topics Artificial Intelligence
Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) Advances Precision Oncology as Biomarker-Driven Cancer Gains Momentum
Via Investor Brand Network
BioMedNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Completes Analytical Reference Standard Program for ONC010
Via Investor Brand Network
Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF): Cancer Nanomedicine Enters a New Generation
Via Investor Brand Network
News headline image
Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API
From Onco-Innovations Limited
Via ACCESS Newswire
InvestorNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Announces Term Sheet for CAD$5 Million Private Placement
Via Investor Brand Network
NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advances ONC010 Manufacturing Development With Nanosoft
Via Investor Brand Network
News headline image
Onco-Innovations Announces Term Sheet for Notional CAD$5 Million Performance-Based Funding Arrangement and Amendments to Previously Announced Financing
From Onco-Innovations Limited
Via ACCESS Newswire
News headline image
Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010
From Onco-Innovations Limited
Via ACCESS Newswire
Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) Advances Manufacturing and Development Efforts as It Pursues a Novel Approach to Hard-to-Treat Cancers
Via Investor Brand Network
News headline image
Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
From Onco-Innovations Limited
Via ACCESS Newswire
NetworkNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in NetworkNewsAudio Editorial on DNA Repair Therapies
Via Investor Brand Network
News headline image
NetworkNewsAudio Announces Audio Press Release (APR) Discussing the Development of PNKP Inhibitors in Oncology Drug Development
From NetworkNewsWire
Via GlobeNewswire
News headline image
InvestorNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in BioMedWire Editorial on Emerging DNA Repair Inhibitors
Via Investor Brand Network
News headline image
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes
From Onco-Innovations Limited
Via GlobeNewswire
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
Via Investor Brand Network
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Targets Next Generation of DNA Damage Response Cancer Therapies
Via Investor Brand Network
Topics Artificial Intelligence
InvestorNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Engages Nanosoft to Advance ONC010 Development Program
Via Investor Brand Network
News headline image
Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
From BioMedWire
Via GlobeNewswire
News headline image
Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
From Onco-Innovations Limited
Via ACCESS Newswire
BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in BioMedWire Editorial on DNA Repair Cancer Therapies
Via Investor Brand Network
News headline image
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advancing Nanoparticle-Encapsulated PNKP Inhibitor in Oncology Space
From Onco-Innovations Limited
Via GlobeNewswire

Frequently Asked Questions

Is ONNVF publicly traded?
Yes, ONNVF is publicly traded.
What exchange does ONNVF trade on?
ONNVF trades on the OTC Traded
What is the ticker symbol for ONNVF?
The ticker symbol for ONNVF is ONNVF on the OTC Traded
What is the current price of ONNVF?
The current price of ONNVF is 0.4309
When was ONNVF last traded?
The last trade of ONNVF was at 08/06/26 09:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.